Cargando…
Idalopirdine – a small molecule antagonist of 5-HT(6) with therapeutic potential against obesity
5HT(6) receptor antagonists offer the potential for safe and effective drugs against obesity, because they can reduce weight without causing serious side effects in the cardiovascular system. Also, their anorexic effect is associated with reduced food intake via an enhancement of satiety. In the pre...
Autores principales: | Dudek, Magdalena, Marcinkowska, Monika, Bucki, Adam, Olczyk, Adrian, Kołaczkowski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642593/ https://www.ncbi.nlm.nih.gov/pubmed/26419385 http://dx.doi.org/10.1007/s11011-015-9736-3 |
Ejemplares similares
-
Idalopirdine, a selective 5-HT(6) receptor antagonist, reduces food intake and body weight in a model of excessive eating
por: Kotańska, Magdalena, et al.
Publicado: (2018) -
Dual Molecules
Targeting 5-HT(6) and
GABA-A Receptors as a New Approach to Combat Depression Associated
with Neuroinflammation
por: Marcinkowska, Monika, et al.
Publicado: (2023) -
Novel serotonin 5-HT(2A) receptor antagonists derived from 4-phenylcyclohexane-5-spiro-and 5-methyl-5-phenyl-hydantoin, for use as potential antiplatelet agents
por: Czopek, Anna, et al.
Publicado: (2021) -
Structural Modeling of TRPA1 Ion Channel—Determination of the Binding Site for Antagonists
por: Gawalska, Alicja, et al.
Publicado: (2022) -
H(3) histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice
por: Dudek, Magdalena, et al.
Publicado: (2016)